slotkoers
Shanghai S.E.
00:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
13,7
CNY
|
+5,14%
|
|
+3,47%
|
-8,67%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
29.701
|
32.706
|
52.058
|
29.075
|
24.169
|
22.075
|
-
|
-
|
Bedrijfswaarde
1 |
29.701
|
32.706
|
52.058
|
29.075
|
24.169
|
22.075
|
22.075
|
22.075
|
K/w-verhouding
|
49,4
x
|
40,4
x
|
47,7
x
|
26,9
x
|
-125
x
|
24
x
|
14,3
x
|
13,4
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
12
x
|
11,2
x
|
14,1
x
|
7,83
x
|
6,15
x
|
5,05
x
|
3,64
x
|
3,24
x
|
Bedrijfswaarde/omzet
|
12
x
|
11,2
x
|
14,1
x
|
7,83
x
|
6,15
x
|
5,05
x
|
3,64
x
|
3,24
x
|
Bedrijfswaarde/EBITDA
|
41,7
x
|
32
x
|
40,8
x
|
22,1
x
|
-
|
17,6
x
|
11,1
x
|
10,4
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
10
x
|
9,2
x
|
9,8
x
|
4,77
x
|
4,22
x
|
3,33
x
|
2,43
x
|
2,1
x
|
Aantal aandelen (in duizenden)
|
1.573.132
|
1.573.368
|
1.611.324
|
1.611.717
|
1.611.291
|
1.611.291
|
-
|
-
|
Referentieprijs
2 |
18,88
|
20,79
|
32,31
|
18,04
|
15,00
|
13,70
|
13,70
|
13,70
|
Datum van publicatie
|
29/04/20
|
26/04/21
|
26/04/22
|
27/04/23
|
26/04/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
2.470
|
2.915
|
3.687
|
3.713
|
3.931
|
4.373
|
6.071
|
6.819
|
EBITDA
1 |
712,6
|
1.021
|
1.275
|
1.313
|
-
|
1.251
|
1.985
|
2.117
|
Bedrijfsresultaat (EBIT)
1 |
667,6
|
877
|
1.182
|
1.174
|
-294,7
|
1.031
|
1.733
|
1.855
|
Operationele Marge
|
27,03%
|
30,09%
|
32,06%
|
31,61%
|
-7,5%
|
23,57%
|
28,55%
|
27,21%
|
Resultaat voor belastingen (EBT)
1 |
680,4
|
914,6
|
1.204
|
1.185
|
-294,8
|
1.031
|
1.741
|
1.855
|
Nettowinst (verlies)
1 |
605
|
806,1
|
1.059
|
1.091
|
-189,4
|
922,8
|
1.545
|
1.652
|
Nettomarge
|
24,5%
|
27,66%
|
28,73%
|
29,38%
|
-4,82%
|
21,1%
|
25,46%
|
24,22%
|
WPA
2 |
0,3823
|
0,5148
|
0,6769
|
0,6700
|
-0,1200
|
0,5700
|
0,9575
|
1,025
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29/04/20
|
26/04/21
|
26/04/22
|
27/04/23
|
26/04/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
22,5%
|
24,5%
|
25,3%
|
18,8%
|
-3,17%
|
13,9%
|
16,9%
|
15,8%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
11,2%
|
12,4%
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
8.239
|
12.462
|
-
|
Nettoactief per aandeel
2 |
1,880
|
2,260
|
3,300
|
3,790
|
3,560
|
4,110
|
5,630
|
6,520
|
Cashflow per aandeel
2 |
-0,5300
|
-0,3600
|
0,4200
|
0,3700
|
1,000
|
0,1400
|
0,3400
|
0,4400
|
Capex
1 |
115
|
294
|
440
|
470
|
419
|
452
|
493
|
570
|
Capex/omzet
|
4,66%
|
10,09%
|
11,94%
|
12,66%
|
10,66%
|
10,34%
|
8,12%
|
8,36%
|
Datum van publicatie
|
29/04/20
|
26/04/21
|
26/04/22
|
27/04/23
|
26/04/24
|
-
|
-
|
-
|
Laatste slotkoers
13,7
CNY Gemiddelde koersdoel
16,32
CNY Spread / Gemiddelde doel +19,09% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -8,67% | 3,05 mld. | | +26,08% | 662 mld. | | +21,85% | 546 mld. | | -4,77% | 359 mld. | | +16,97% | 323 mld. | | +5,69% | 290 mld. | | +13,68% | 234 mld. | | +3,65% | 198 mld. | | -11,12% | 194 mld. | | +8,08% | 167 mld. |
Farmaceutische producten - Andere
|